FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901471644> ?p ?o ?g. }

• W2901471644 endingPage "e0207224" @default.
• W2901471644 startingPage "e0207224" @default.
• W2901471644 abstract "Response to neoadjuvant chemotherapy in breast cancer patients is of prognostic value in determining short- and mid-term outcomes. Inflammatory biomarkers, such as platelet-to-lymphocyte ratio (PLR) and neutrophil to lymphocyte ratio (NLR), have been proposed as predictive factors of response to neoadjuvant chemotherapy. Currently, there are no studies in Colombian patients reporting the role of inflammatory biomarkers as response predictors in patients receiving neoadjuvant chemotherapy. Therefore, in this study we performed a cross-sectional study and analyzed the association between inflammatory biomarkers and pCR (pathological complete response) in patients diagnosed with breast cancer–of different molecular subtypes- and treated with neoadjuvant chemotherapy. A total of 288 patients were included in the study, with a median age of 51 years old. Disease was locally advanced in 83% of the participants, and 77.7% had compromised lymph nodes. In our cohort, the most frequent tumor molecular subtype was luminal B/Her2- (27.8%) followed by triple negative [TN] (21.5%), luminal B/Her2+ (19.8%), Her2-enriched (16%) and luminal A (13.5%). PLR was not associated with age, menopausal status, baseline tumor size, histologic grade, axillary lymph node involvement, disease stage, estrogen receptor status, or Ki67; however, complete pathological response was significantly higher in the low PLR group (PLR<150) compared with the high PLR group (35.1% Vs. 22.2%, p = 0.03). In addition, Her2-enriched tumors achieved the highest pCR rates (65%), followed by TN (34%) tumors. Our results suggest that breast cancer patients with low platelet-to-lymphocyte ratio (PLR <150), treated with neoadjuvant chemotherapy achieve higher complete pathological response, independently of primary tumor molecular subtype." @default.
• W2901471644 created "2018-11-29" @default.
• W2901471644 creator A5012845775 @default.
• W2901471644 creator A5015275329 @default.
• W2901471644 creator A5044403223 @default.
• W2901471644 creator A5089373655 @default.
• W2901471644 date "2018-11-14" @default.
• W2901471644 modified "2023-09-27" @default.
• W2901471644 title "Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer" @default.
• W2901471644 cites W1586470106 @default.
• W2901471644 cites W1841839849 @default.
• W2901471644 cites W1956784352 @default.
• W2901471644 cites W1982453726 @default.
• W2901471644 cites W1986632581 @default.
• W2901471644 cites W1993702531 @default.
• W2901471644 cites W1993896523 @default.
• W2901471644 cites W2006070721 @default.
• W2901471644 cites W2009098155 @default.
• W2901471644 cites W2016722329 @default.
• W2901471644 cites W2020684281 @default.
• W2901471644 cites W2067971776 @default.
• W2901471644 cites W2075894019 @default.
• W2901471644 cites W2088574179 @default.
• W2901471644 cites W2096145980 @default.
• W2901471644 cites W2099005045 @default.
• W2901471644 cites W2113187757 @default.
• W2901471644 cites W2117083748 @default.
• W2901471644 cites W2117692326 @default.
• W2901471644 cites W2117775530 @default.
• W2901471644 cites W2119549339 @default.
• W2901471644 cites W2120431466 @default.
• W2901471644 cites W2125885282 @default.
• W2901471644 cites W2133569215 @default.
• W2901471644 cites W2147415463 @default.
• W2901471644 cites W2154142993 @default.
• W2901471644 cites W2168064072 @default.
• W2901471644 cites W2168299243 @default.
• W2901471644 cites W2169945437 @default.
• W2901471644 cites W2221588520 @default.
• W2901471644 cites W2340735966 @default.
• W2901471644 cites W2419617026 @default.
• W2901471644 cites W2420462095 @default.
• W2901471644 cites W2487595537 @default.
• W2901471644 cites W2527994266 @default.
• W2901471644 cites W2528841985 @default.
• W2901471644 cites W2557243782 @default.
• W2901471644 cites W2593789165 @default.
• W2901471644 doi "https://doi.org/10.1371/journal.pone.0207224" @default.
• W2901471644 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6235359" @default.
• W2901471644 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30427884" @default.
• W2901471644 hasPublicationYear "2018" @default.
• W2901471644 type Work @default.
• W2901471644 sameAs 2901471644 @default.
• W2901471644 citedByCount "33" @default.
• W2901471644 countsByYear W29014716442019 @default.
• W2901471644 countsByYear W29014716442020 @default.
• W2901471644 countsByYear W29014716442021 @default.
• W2901471644 countsByYear W29014716442022 @default.
• W2901471644 countsByYear W29014716442023 @default.
• W2901471644 crossrefType "journal-article" @default.
• W2901471644 hasAuthorship W2901471644A5012845775 @default.
• W2901471644 hasAuthorship W2901471644A5015275329 @default.
• W2901471644 hasAuthorship W2901471644A5044403223 @default.
• W2901471644 hasAuthorship W2901471644A5089373655 @default.
• W2901471644 hasBestOaLocation W29014716441 @default.
• W2901471644 hasConcept C121608353 @default.
• W2901471644 hasConcept C126322002 @default.
• W2901471644 hasConcept C143998085 @default.
• W2901471644 hasConcept C207886595 @default.
• W2901471644 hasConcept C2776694085 @default.
• W2901471644 hasConcept C2778292576 @default.
• W2901471644 hasConcept C2780521871 @default.
• W2901471644 hasConcept C2780839634 @default.
• W2901471644 hasConcept C2780849966 @default.
• W2901471644 hasConcept C530470458 @default.
• W2901471644 hasConcept C71924100 @default.
• W2901471644 hasConcept C90924648 @default.
• W2901471644 hasConceptScore W2901471644C121608353 @default.
• W2901471644 hasConceptScore W2901471644C126322002 @default.
• W2901471644 hasConceptScore W2901471644C143998085 @default.
• W2901471644 hasConceptScore W2901471644C207886595 @default.
• W2901471644 hasConceptScore W2901471644C2776694085 @default.
• W2901471644 hasConceptScore W2901471644C2778292576 @default.
• W2901471644 hasConceptScore W2901471644C2780521871 @default.
• W2901471644 hasConceptScore W2901471644C2780839634 @default.
• W2901471644 hasConceptScore W2901471644C2780849966 @default.
• W2901471644 hasConceptScore W2901471644C530470458 @default.
• W2901471644 hasConceptScore W2901471644C71924100 @default.
• W2901471644 hasConceptScore W2901471644C90924648 @default.
• W2901471644 hasIssue "11" @default.
• W2901471644 hasLocation W29014716441 @default.
• W2901471644 hasLocation W29014716442 @default.
• W2901471644 hasLocation W29014716443 @default.
• W2901471644 hasLocation W29014716444 @default.
• W2901471644 hasLocation W29014716445 @default.
• W2901471644 hasOpenAccess W2901471644 @default.
• W2901471644 hasPrimaryLocation W29014716441 @default.
• W2901471644 hasRelatedWork W1255356622 @default.

• next